Genetics of bladder cancer

Journal of Molecular Medicine

Volumn 74, Issue 8, 1996, Pages 441-445

  Saran, K K ^a   Gould, D ^a   Godec, C J ^a   Verma, R S ^a  

^a LONG ISLAND COLLEGE HOSPITAL   (United States)

Author keywords

Amplification; Bladder carcinoma; Chromosomes; Loss of heterozygosity; p53; Point mutation; Proto oncogenes; Tumor suppressor genes

Indexed keywords

BLADDER CARCINOMA; CANCER GRADING; CANCER INVASION; CHROMOSOME 9P; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; POINT MUTATION; PROGNOSIS; PROTO ONCOGENE; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0029746643     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00217519     Document Type: Review

References (79)

1. Catulona WJ (1992) Urothelial tumors of the urinary tract. In: Walsh PC, Retik AB, Stamey TA, Vaughan ED (eds) Campbell's urology. 6th edn. Saunders, Philadelphia, pp 1094-1158
2. Wingo PA, Tong T, Bolden S (1995) Cancer statistics. CA Cancer J Clin 45:8-30
3. Koss L (1992) Diagnostic cytology. 4th edn. Lippincott, Philadelphia, pp 934-976
4. Gibas Z, Prout GR Jr, Connolly JG, Pontes JE, Sandberg AA (1984) Non-random chromosomal changes in transitional cell carcinoma of the bladder. Cancer Res 44:1257-1264
5. Atkin NB, Baker MC (1985) Cytogenetic study of ten carcinoma of the bladder: involvement of chromosome 1 and 11. Cancer Genet Cytogenet 15:253-268
6. Berger CS, Sandberg AA, Todd IAD, Pennington RD, Haddad FS, Hecht BK, Hecht F (1986) Chromosomes in kidney, ureter, and bladder cancer. Cancer Genet Cytogenet 23:1-24
7. Sandberg AA (1986) Chromosome changes in bladder cancer: clinical and other correlations. Cancer Genet Cytogenet 19:163-175
8. Smeets W, Pauwels R, Laarakkers L, Debruyne F, Geraedts J (1987) Chromosomal analysis of bladder cancer. III. Non-random alterations. Cancer Genet Cytogenet 29:29-41
9. Hopman AHN, Ramaekers FCS, Raap AK, Beck JLM, Deville P van der Ploeg M, Vooijs GP (1988) In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry 89:307-316
10. Hopman AHN, Moesker O, Smeets AWGB, Pauwels RPE, Vooijs GP, Ramaekers FCS (1992) Numerical chromosome 1, 7, 9 and 11 aberrations in bladder cancer detected by in situ hybridization. Cancer Res 51:644-651
11. Tyrkus M, Powell T, Fakr W (1992) Cytogenetic studies of carcinoma in situ of the bladder: prognostic implication. J Urol 148:44-46
12. Meloni AM, Peir AM, Haddad FS, et al (1993) A new approach in the diagnosis and follow-up of bladder cancer: FISH analysis of urine, bladder washings and tumors. Cancer Genet Cytogenet 71:105-188
13. Wang MR, Perissel B, Taillandier J, Kemeny JL, Fonckl Y, Lautier A, Benkhalifa M, Malet P (1994) Nonrandom changes of chromosome 10 in bladder cancer: detection by FISH to interphase nuclei. Cancer Genet Cytogenet 73:8-10
14. Matsuyama H et al (1994) Nonrandom numerical aberrations of chromosomes 7, 9 and 10 in DNA-diploid bladder cancer. Cancer Genet Cytogenet 77:188-124
15. 53 expression in a small cell carcinoma of the bladder. Cancer Genet Cytogenet 79:111-114
16. Sidransky D, Frost P, Von Eschenbach A, Oyasu R, Preisinger AC, Vogelstein B (1992) Clonal origin of bladder cancer. N Engl J Med 326:737-740
17. Liu BCS, Liotta LA (1992) Biochemistry of bladder cancer invasion and metastasis: clinical implications. Urol Clin North Am 19:621-627
18. Fearon ER, Hamilton SR, Vogelstein B (1987) Clonal analysis of human colorectal tumors. Science 238:193-197
19. Klein HA, Chaganti RS et al (1992) Genes of transitional cell carcinoma. Sem Surg Oncol 8:260-266
20. Knowles MA, Williamson MP, (1995) Mutation of H-ras is infrequent in bladder cancer: confirmation polymorphism analysis, designed restriction fragment length polymorphisms and direct sequencing. Cancer Res 53:133-139
21. Levesque P, Ramchurren N, Saini K et al (1993) Screening of human bladder tumors and urine sediments for the presence of H-ras mutations. Int J Cancer 55:785-790
22. Coombs LM, Pigott DA, Sweeney H et al (1991) Amplification and overexpression of c-erbB-2 in transitional cell carcinoma of the urinary bladder. Br J Cancer 63:601-608
23. Sauter G, Moch D, Moore P et al (1993) Heterogeneity of erbB-2 gene amplification in bladder cancer. Cancer Res 53:2199-2203
24. Proctor AJ, Coombs LM, Cairns JP et al (1991) Amplification at chromosome 11q13 in transitional cell tumours of the bladder. Oncogene 6:789-795
25. Bringuier PP, Tainimi J, Schuuring E et al (1994) Amplification of the chromosome 11q13 region in bladder tumors. Urol Res 21:451
26. Bishop JM (1991) Molecular theme in oncogenesis. Cell 64: 235-248
27. Klein UA, Fair WR, Changanti RSK (1988) Molecular and cytogenetic event in bladder cancer. Semin Urol 6:2-21
28. Gibas Z, Sandberg AA (1984) Chromosomal rearrangements in bladder cancer. Urology [3 Suppl]:3-9
29. Vanni R, Scarpa RM. Nieddu M et al (1988) Cytogenetic investigation on 30 bladder carcinomas. Cancer Genet Cytogenet 30:35-42
30. Keen AJ, Knowles MA, (1994) Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder. Oncogene 9:2083-2088
31. Cairns P, Tokino T, Eby Y et al (1994) Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction. Cancer Res 54: 1422-1424
32. Presti Jr JC, Reuter VH, Galan T et al (1991) Molecular genetic alterations in superficial and locally advanced human bladder cancer. Cancer Res 51:5405-5409
33. Brewster SF, Gingell JC, Browne S et al (1994) Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder. Br J Cancer 70:697-700
34. Sauter G, Moch H, Carroll P et al (1995) Chromosome-9 loss detected by fluorescence in-situ hybridization in bladder cancer. Int J Cancer 64:99-103
35. Knowles MA, Elder PA, Williamson M et al (1994) Allelotype of human bladder cancer. Cancer Res 54:531-538
36. Tsai YC, Nichols PW, Hiti AL, et al (1990) Allelic losses of chromosomes 9, 11 and 17 in human bladder cancer. Cancer Res 50:44-47
37. Cairns P, Shaw ME, Knowles MA (1993) Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9. Oncogene 8:1083-1085
38. Cairns P, Shaw ME, Knowles MA (1993) Preliminary mappine of the deleted region of chromosome 9 in bladder cancer. Cancer Res 53:1230-1232
39. Linnenbach AJ, Pressler LB, Seng BA et al (1993) Characterization of chromosome 9 deletions in transitional cell carcinoma by microsatellite assay. Hum Mol Genet 2:1407-1411
40. Miyao N, Tsai YC, Lerner SP et al (1993) Role of chromosome 9 in human bladder cancer. Cancer Res 53:4066-4070
41. Ruppert JM, Tokino K, Sidransky D (1993) Evidence for two bladder cancer suppressor loci on human chromosome 9. Cancer Res 53:5093-5095
42. Fearon HR, Feinberg AP, Hamilton SH et al (1985) Loss of genes on the short arm of chromosome 11 in bladder cancer. Nature 318:377-380
43. Shaw ME, Knowles MA (1995) Deletion mapping of chromosome 11 in carcinoma of the bladder. Genes Chromosom Cancer 13:1-8
44. Knowles MA, Shaw MR. Proctor AJ (1993) Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms. Oncogene 8:1357-1364
45. Sidransky D, Tsai YC, Paul V, Vogelstein B et al (1991) Identification of P53 gene mutation in bladder cancer and urine samples. Science 252:706-709
46. Miyamoto H, Shuin T, Torigoe S, Iwasaki Y, Kubota Y (1995) Retinoblastoma gene mutations in primary human bladder cancer. Br J Cancer 71:831-835
47. Dalbagni G, Presti J, Reuter V, Lair WR, Cordoncardo C (1994) Genetic alterations in bladder cancer. Lancet 342:469-471
48. Spruck H, Ohneseit PL, Tsai YC, et al (1994) Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 54:784-788
49. 53 function in separate pathways of tumor suppression. Am J Path 146:1199-1206
50. Rider PA, Bell SM, Knowles MA (1994) Deletion of two regions on chromosome 4 in bladder carcinoma: definitions of a critical 750kb region at 4p16.3 oncogene 12:3433-3436
51. 53 nuclear overexpression in human bladder cancer. Diagn Mol Pathol 2:4-13
52. Sidransky D et al (1993) Molecular genetics and biochemical mechanisms in bladder cancer advanced bladder cancer. Oncogenes, tumor suppressor genes and growth factors. Urol Clin North Am 19:629-639
53. Esrig D, Spruck CH, Nicholas PW et al (1993) Nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade ans stage in bladder cancer. Am J Path 143:1389-1397
54. Soini Y, Kamel D, Aatio-Harmainen H et al (1993) p53 Immunohistochemistry in transitional ohistocheinoma and dysplasia of the urinarv bladder correlates with disease progression. Br J Cancer 68:1029-1035
55. Guido W, Delbangi G, Presti J, Reuter V et al (1993) Genetic alteration in bladder cancer. Lancet 342:469-471
56. Ramaekers FC et al (1993) Detection of genetic aberrations in bladder cancer using in situ hybridization. Ann NY Acad Sci 677:199-213
57. Lonn U et al (1993) Gene amplification detected in carcinoma cells from human urinary bladder washings by the polymerase chain reaction method. Cancer 71:3605-3610
58. Reznikoff CA et al (1993) A molecular genetic model of human bladder carcinogenesis. Semin Cancer Biol 4:143-152
59. Borland RN et al (1992) Molecular biology of bladder cancer. Hematol Oncol Clin North Am 6:31-39
60. Fujimoto K, Yamada Y, Okajima E, Kakizoe T, Sasaki H, Suhimura T, Terada M (1992) Frequent association of p53 gene mutations in invasive bladder cancer. Cancer Res 52:1393-1398
61. Saito S, Bannerji R, Gansbacher B, Rosenthal FM et al (1994) Immunotherapy of bladder cancer with cytokine gene-modified tumor vaccines. Cancer Res 54:3516-3520
62. Herr HW (1994) Uncertainty, stage and outcome of invasive bladder cancer. J Urol 152:401-402
63. Droller MJ (1995) New efforts to stage bladder cancer. J Urol 154:385-386
64. Keen AJ, Knowles MA (1994) Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder. Oncogens 9:2083-2088
65. Spruce CH et al (1993) Distinct pattern of p53 mutations in bladder cancer relationship to tobacco usage. Cancer Res 53:1162-1165
66. Sarkis AS et al (1994) Association of p53 nuclear overexpression and tumor progression in carcinoma in-situ of bladder. J UmI 152:388-392
67. Stadler WM, Sherman J, Bohlander SK et al (1994) Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer. Cancer Res 54:2060-2063
68. Herr HW (1992) Staging invasive bladder cancer. J Surg Oncol 51:217
69. Rosin MP, Cairns P, Epstein JI, Schoenberg MP, Sidransky D (1995) Partial allelotype of carcinoma in-situ of the human bladder. Cancer Res 55:5213-5216
70. Sandberg AA, Berger CS (1994) Review of chromosome studies in urological tumors. II Cytogenetics and molecular genetics of bladder cancer. J Urol 151:545-560
71. Cordon-Cardo C, Dulbagni G, Sarkis AS, Reuter UE (1994) Genetic alterations associated with bladder cancer In: De Vita VT, Hellman S, Rosenberg SA (eds) Important advances in oncology. Lippincott, Philadelphia, pp71-83
72. Aprikian AG, Sarkis AS, Reuter VE, Cordon-Curdo C, Sheinfeld J (1993). Biological markers of prognosis in transitional cell carcinoma of the bladder, current concepts. Semin Urol 11:137-144
73. Underwood M, Bartlett J, Reeves J, Gardiner DS, Scott R, Cooke T (1995) G-erbB22 gene amplification: a molecular marker in recurrent bladder tumors? Cancer Res 55:2422-2430
74. Chang WYH, Cairns P, Schoenberg MP, Poluscik TJ, Sidransky D (1995) Novel suppressor loci on chromosome 14q in primary bladder cancer. Cancer Res 55:3246-3249
75. Sanchez-Chapado M et al (1995) Expression of dominant oncogenes and tumor suppressor genes in bladder carcinoma. Arch Esp Urol 48:1-12
76. 53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC. J Clin Oncol 13:1384-1390
77. Gray IC, Phillips SMA, Lee SJ, Neoptolemos JP, Weissenbach JW, Spurr NK (1995) Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res 55:4800-4803
78. Ewing CM, Ru N, Morton RA et al (1995) Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of α-catenin and restoration of E-cadherin function. Cancer Res 55:4813-4817
79. Sauter G et al (1995) Chromosome 9 loss detected by fluorescence in-situ hybridization in bladder cancer. Int J Cancer 64:99-103